Checkmate Pharmaceuticals Inc (CMPI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -36,908 | -25,978 | -16,149 | -7,801 | -28,292 |
| Depreciation Amortization | 188 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 63 | 1,473 | -31 | 10 | 606 |
| Other Working Capital | -3,509 | -2,576 | -177 | -550 | 1,506 |
| Other Operating Activity | 2,055 | -337 | 315 | 91 | -671 |
| Operating Cash Flow | $-38,111 | $-27,418 | $-16,042 | $-8,250 | $-26,851 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -83,290 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-83,290 | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 10,000 | 10,000 | 10,000 | 7,973 | N/A |
| Common Stock Issued | 67,712 | 68,030 | -398 | N/A | N/A |
| Other Financing Activity | 82,559 | 82,543 | 82,544 | 0 | 18,977 |
| Financing Cash Flow | $160,271 | $160,573 | $92,146 | $7,973 | $18,977 |
| Beginning Cash Position | 4,205 | 4,205 | 4,205 | 4,205 | 12,079 |
| End Cash Position | 43,075 | 137,360 | 80,309 | 3,928 | 4,205 |
| Net Cash Flow | $38,870 | $133,155 | $76,104 | $-277 | $-7,874 |
| Free Cash Flow | |||||
| Operating Cash Flow | -38,111 | -27,418 | -16,042 | -8,250 | -26,851 |
| Free Cash Flow | -38,111 | -27,418 | -16,042 | -8,250 | -26,851 |